Dr. Alessandro Santin
Claim this profileSmilow Cancer Hospital at Yale New Haven
Area of expertise
Ovarian Cancer
Alessandro Santin has run 8 trials for Ovarian Cancer. Some of their research focus areas include:
Endometrial Cancer
Alessandro Santin has run 6 trials for Endometrial Cancer. Some of their research focus areas include:
Affiliated Hospitals
Smilow Cancer Hospital At Yale-New Haven
Yale University School Of Medicine
Clinical Trials Alessandro Santin is currently running
Avutometinib + Defactinib
for Ovarian Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.
Recruiting
2 awards
Phase 3
8 criteria
IMGN853
for Endometrial Cancer
The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial cancers that overexpress folate receptor alpha (FRα).
Recruiting
1 award
Phase 2
15 criteria
More about Alessandro Santin
Clinical Trial Related
6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Alessandro Santin has experience with
- Carboplatin
- Paclitaxel
- Sacituzumab Govitecan
- Pembrolizumab
- Topotecan
- Mirvetuximab Soravtansine
Breakdown of trials Alessandro Santin has run
Ovarian Cancer
Endometrial Cancer
Fallopian Tube Cancer
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alessandro Santin specialize in?
Alessandro Santin focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are FRα positive.
Is Alessandro Santin currently recruiting for clinical trials?
Yes, Alessandro Santin is currently recruiting for 4 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Alessandro Santin has studied deeply?
Yes, Alessandro Santin has studied treatments such as Carboplatin, Paclitaxel, Sacituzumab Govitecan.
What is the best way to schedule an appointment with Alessandro Santin?
Apply for one of the trials that Alessandro Santin is conducting.
What is the office address of Alessandro Santin?
The office of Alessandro Santin is located at: Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut 06520 United States. This is the address for their practice at the Smilow Cancer Hospital at Yale New Haven.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.